
@NSF Postdoctoral Fellow in @BaranLabReads, @ScrippsResearch | PhD in Hadt Lab, @CaltechCCE | @theNASEM Ford & @NSF GRFP Fellow | Founder of Caltech Rising Tide
San Diego, CA
Joined January 2020
- Tweets349
- Following452
- Followers482
- Likes8.5K
David Cagan retweeted
ChemASAP 1.1 is live on the App Store! 🧪📱
Thanks to all of you for the amazing feedback. Here's what's new:
📚 63 journals (pick the ones you want): RSC titles incl. Chem Sci, Chem Comm, OBC, Green Chem & Chem Soc Rev, plus Inorg Chem, Anal Chem, JPCL, Chem Mater, Macromolecules, Chem Eur J, EurJOC, Adv Synth Catal, Synthesis, Synlett, med chem titles like ACS Med Chem Lett, Nat Chem Bio, Cell Chem Bio & more
👉 Swipe right to save a paper, swipe left to mark it read
🔖 Saved list and "Hide read" so you know when you're all caught up
🔓 Open-access badge on free-to-read papers
🗂️ Journal picker grouped by field, with search
🏷️ Labels that match each publisher (ASAP, Early View, In Press, Latest)
Still free, no account needed.
Android is in testing now and coming soon (if you signed up for the testing, it will go live for you this week)!
apps.apple.com/us/app/chemas…
David Cagan retweeted
When ACS shut down its mobile app, a lot of us lost the easiest way to keep up with some of the literature. Generic RSS readers are flaky, strip out images, and force you to bounce between publishers — while new chemistry papers are coming out at a firehose pace.
All most of us want is to open one app, scroll the latest ASAPs, and actually see the graphical abstracts first — because chemists read in structures, not walls of text.
So we built ChemASAP 🧪⚡
Open one app and see the newest ASAP and early-view papers (publisher agnostic), with their graphical abstracts front and center.
• Pulls crisp TOC / graphical abstracts automatically – even when a publisher's RSS feed breaks or leaves them out
• Works across publishers in one clean feed (ACS, Nature, Wiley, RSC, Cell Press/Chem, Science, and more — not locked to one house)
• Treats @ChemRxiv as a first-class journal right alongside peer-reviewed ASAPs
• Toggle only the journals you care about, tap straight to full text, or share a paper in one tap
• No account, no sign-up
100% Free for everyone.
So far, its been our go-to app for keeping track of the literature in real-time.
📱 iPhone/iPad: apps.apple.com/us/app/chemas…
💻 Web: api.baranlab.org
Reply here with ideas for how to make it better!
Shout out to @knight_chem for sponsorship and @bot for development.
David Cagan retweeted
New in JACS: "Rigor and Reproducibility in Electrocatalysis: Integrating Theory and Experiment" go.acs.org/eTN
David Cagan retweeted
Stop sampling accessible isomers. Start building the target matrix.
Saturated heterocycles bearing covalent reactive groups already appear in more than a dozen FDA-approved medicines, including ritlecitinib and ibrutinib, making systematic exploration of this space directly relevant to medicine. When covalently reactive molecules are screened by proteomics to discover new protein engagements, the relevant unit of design is no longer a single compound—it is the complete set of regio- and stereoisomers of a privileged scaffold. Incomplete libraries, constrained by synthetic bias, systematically miss the very interactions they set out to find.
Radical cross-coupling removes that constraint. By pairing stereorandomizing and stereopreserving manifolds from simple commercial precursors, we constructed exhaustive piperidine (40) and pyrrolidine (24) matrices and expanded the collection to 108 covalent stereoprobes. Proteome-wide ABPP revealed highly differentiated, stereoselective engagements that further diversified with the choice of covalent reactive group. Selected hits were characterized by X-ray, and protein-directed ABPP expanded the observable ligandability landscape still further.
A collaboration with @VividionRx and the Cravatt lab, appearing today in @ChemRxiv: chemrxiv.org/doi/full/10.264…
David Cagan retweeted
The radical-radical cross-coupling of alkyl carboxylic acids and organoborons ( @NatureChemistry ): nature.com/articles/s41557-0… ( @ortho_maxb @CAMalapit ).
David Cagan retweeted
So excited for @NSF_CSOE to be bringing new electrosynthesis teaching labs to the organic chemistry community! Electrochemical
Alcohol Oxidation: An Accessible Electrosynthesis
Experiment for Sophomore-Level Organic Chemistry pubs.acs.org/jceda8/article-…
We’re proud to announce that Harry B. Gray and Jay R. Winkler have been named Citation Laureates 2026 by @ClarivateAG! Their pioneering research in Chemistry is shaping the future of science.
#CitationLaureates #CitationLaureates2026
David Cagan retweeted
Now online: Chemoselective Ni-catalysed directed C(sp2)–H alkylation at low temperature using alkyl sulfonylhydrazides go.nature.com/3VjoVnr 🧪
Out in print now ! 🙌
Final version out today in @NatureSynthesis : nature.com/articles/s44160-0…
4
327
David Cagan retweeted
Two directions. One radical move.
Simultaneous two-directional catalytic radical cross-coupling, a great collaboration with Abbvie (@KaidHarper), is out now in @ChemRxiv (chemrxiv.org/doi/full/10.264…)
Diacid-derived bis-RAEs undergo Ag–Ni electrocatalytic decarboxylative arylation → functionalized dibenzyl amines & linkers.
Diamine-derived bis-sulfonyl hydrazides deliver redox-neutral deaminative RCC → decorated carbon skeletons.
Chemoselective. Scalable. Modular access to valuable products from simple, symmetrical starting materials — including PROTAC-style linkers with C–C bonds instead of amides.
The classic two-directional logic of @SchreiberStuart, now fully radical.
David Cagan retweeted
Radical cross-coupling, simplified. No specialized equipment. No exogenous redox. No stoichiometric organometallics. The best part is no part.
A perspective on the field, appearing today in @ChemRxiv : chemrxiv.org/doi/full/10.264…
David Cagan retweeted
RCC to the RESCUE: A rapid, convergent synthesis of roussoellatide enabled by redox-neutral radical cross-coupling, completed by @Nima_Nasiri_. A case study in how RCC prevails when classical polar methods fail. Out now in @ChemRxiv : chemrxiv.org/doi/abs/10.2643…
David Cagan retweeted
Textbook tells you that Cys-conjugation is driven by thiolate. The logic was simple: e-poor acceptor, high pH, more S-, and fast reaction.
But our (@BaranLabReads ) reagent reacts fastest under mild acidic pH and was boosted by EDG—the exact opposite!!!
Check this out!! 👇
A Kinetics-first Approach Reveals Optimum Vinylaminopyrimidines for Cysteine-Based Antibody Conjugation – an exciting collaboration with @scrippsresearch colleagues @Dawson_Group and the Blackmond group along with BMS – appearing now in @ChemRxiv : chemrxiv.org/doi/abs/10.2643…
David Cagan retweeted
A Kinetics-first Approach Reveals Optimum Vinylaminopyrimidines for Cysteine-Based Antibody Conjugation – an exciting collaboration with @scrippsresearch colleagues @Dawson_Group and the Blackmond group along with BMS – appearing now in @ChemRxiv : chemrxiv.org/doi/abs/10.2643…
Introducing kSAR: Conjugation kinetics was leveraged to identify key scaffolds for med chem ! Here we show the power of blending phys org with synthetic chemistry for medicinal applications
A Kinetics-first Approach Reveals Optimum Vinylaminopyrimidines for Cysteine-Based Antibody Conjugation – an exciting collaboration with @scrippsresearch colleagues @Dawson_Group and the Blackmond group along with BMS – appearing now in @ChemRxiv : chemrxiv.org/doi/abs/10.2643…
David Cagan retweeted
Final version appearing today in @NatureChemistry : rdcu.be/fu8bX
👋DRUG HUNTERS👋 N₂ extrusion from alkyl hydrazines delivers complex, medicinally relevant alkyl S(VI)-chemical space with exceptional chemoselectivity and operational simplicity.
Appearing today in @ChemRxiv: chemrxiv.org/doi/full/10.264…
Alkyl hydrazines (or their sulfonyl derivatives) serve as practical radical precursors readily prepared from ketones, alcohols, amines, and complex molecules. Simple thermal activation triggers clean N₂ extrusion to generate alkyl radicals that are captured by inexpensive SO₂ sources, delivering versatile sulfinates convertible in situ to sulfonyl fluorides or sulfinamides.
70+ examples, protecting-group-free late-stage functionalization of natural products and drugs (ticagrelor, erythromycin, spiramycin), 100-g scale with trivial work-up, and stereoretentive variants round out a unified platform that directly addresses the growing need for complex alkyl S(VI) motifs in medicinal chemistry. Detailed mechanistic studies, including temperature scanning calorimetry, radical clocks, and DFT calculations help to demystify the process.
David Cagan retweeted
Appearing today as an Accelerated Article Preview publication in @Nature :nature.com/articles/s41586-0…
Making C-glycosides SWEET and simple! Today in @ChemRxiv we disclose (chemrxiv.org/doi/full/10.264…), in collaboration with @GroupAggarwal, an incredibly easy way to achieve radical functionalization of sugars. In this video (youtu.be/Fqdbgmx7zEI), a two-step synthesis of the billion dollar drug Dapagliflozin is achieved using household vinegar and dextrose powder from the local supplement store.
High Level Summary:
The work addresses a longstanding challenge in carbohydrate chemistry: the efficient, scalable, and stereocontrolled synthesis of C-aryl glycosides directly from unprotected native sugars. C-Aryl glycosides form the core pharmacophore of the SGLT2 inhibitors (dapagliflozin, canagliflozin, empagliflozin, and related agents), which are frontline therapies for type 2 diabetes and represent one of the highest-grossing classes of small-molecule drugs.
Conventional synthetic routes to these molecules generally require extensive protecting-group manipulations, multi-step activation of glycosyl donors, or organometallic additions under demanding conditions. Recent advances in radical and transition-metal-catalyzed cross-couplings have improved access, yet most approaches still depend on protected precursors, specialized reagents, or protocols that are difficult to scale.
We report a practical alternative based on glycosyl sulfonyl hydrazides—stable, crystalline radical precursors that are prepared in a single step from unprotected sugars by treatment with tosylhydrazine in acetic acid, followed by simple crystallization. These hydrazides undergo redox-neutral nickel-catalyzed radical cross-coupling with aryl iodides or bromides under mild conditions (70 °C, DMSO, tetramethylguanidine as base). The reaction requires no external oxidant or reductant, no photocatalyst, and no organotin species. In glucose-derived systems the coupling typically delivers high β-selectivity (>19:1 in many cases), an outcome that appears to depend on hydrogen-bonding interactions between tetramethylguanidine and the free hydroxyl groups.
The main findings are as follows:
All five FDA-approved SGLT2 inhibitors, as well as several clinical candidates, can be prepared in a single coupling step from the corresponding glycohydrazide.
Decagram-scale synthesis of dapagliflozin was demonstrated starting from commercial dextrose; the product was isolated by aqueous workup and recrystallization (no column chromatography required at this scale).
Di- and trisaccharides (lactose, cellobiose, maltose, maltotriose) couple directly to give aryl-linked oligosaccharides.
Several natural products and medicinally relevant structures (salmochelin-SX, neopetrosin C, the tryptophan-mannose conjugate, and a ribose-derived IMPDH inhibitor) that previously required 9–20 steps or costly reagents are now accessible in 1–4 steps with good stereocontrol.
The platform extends to non-anomeric C–C bond formation at positions C2–C6 on glucose and ribose scaffolds, providing the first systematic exploration of radical diversification across these positions.
Stereoretentive radical cross-coupling, using configurationally pure hydrazides, enables programmable delivery of either α- or β-anomers, overriding inherent substrate biases and providing access to stereoisomers not previously obtainable by radical methods.
The chemistry builds on our earlier development of sulfonyl hydrazide-based redox-neutral cross-coupling and stereoretentive radical arylation, here adapted and optimized for carbohydrate substrates. The method is operationally straightforward, uses inexpensive reagents and starting materials, and eliminates protecting-group strategies.
David Cagan retweeted
Chemists from @BaranLabReads report a new stereoretentive radical-radical cross-coupling reaction that enables alkyl–alkyl bond formation while maintaining 80–96% enantiospecificity. Published in @ScienceMagazine, the method works across a wide range of pharmaceutically relevant molecules, offering a useful new tool for drug discovery. More: ow.ly/2Aa750Za5pl
David Cagan retweeted
‘Absurd’ radical reaction keeps stereochemistry intact cen.acs.org/synthesis/absurd… via @cenmag





















